Xie, Long
Zhu, Xiao-Ya
Xu, Li
Xu, Xiao-Xie
Ruan, Ze-Fan
Huang, Ming-Xiang
Chen, Li
Jiang, Xi-Wen
Funding for this research was provided by:
Guangzhou Municipal Bureau of Science and Technology (202102010053)
Guangdong Provincial Department of Science and Technology (2022B1111020003)
Article History
Received: 26 October 2023
Accepted: 10 May 2024
First Online: 17 June 2024
Declarations
:
: All authors declare no competing interests as defined by Springer, or other interests that might be perceived to influence the results and/or discussion reported in this paper.
: This study received institutional approval from the Research Ethics Committee of Chaoshan Hospital (Approval number: CREA-CSH2021-003), affiliated with Jinan University First Affiliated Hospital, and the Medicine and Biological Engineering Technology Research Centre of the Ministry of Health, Guangzhou, China. This approval was in line with the Helsinki declaration as revised in 2013 and its later amendments. All participants provided written informed consent to the collection, the storage and the use of biological samples for scientific analysis before participating in the study. To ensure ethical compliance, data pertinent to disease control were collected and subsequently anonymized for analysis. All experimental protocols of this study were performed following national technical specification for TB prevention and control.